Skip to main content

Dashboard
Companies
News
Insiders
Politicians
Institutions
ETFs
Crypto
Press Releases
SEC Filings
Alerts
Pre-Market
Calendar

⌘K

·

Home
Insiders
Jiangsu Hengrui Pharmaceuticals Co Ltd

/

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

SEC insider (Form 3/4/5 filer). CIK 0002080343. 222 filings on record. Located in LIANYUNGANG.

Companies Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed insider trades for

Braveheart Bio, Inc. (BRVE) — 10% Owner
Kailera Therapeutics, Inc. (KLRA) — 10% Owner

?

Activity (Lifetime)

Total Transactions

Buys

Sells

Buy:Sell Ratio

Net Shares Change

Coverage

Companies Covered

Primary Company

Primary Role

Filing Dates

First Trade

Last Trade

Latest Filing

By SEC Code

P - Open-Market Buys

S - Open-Market Sales

M - Exercises

A - Awards

Other (incl. F)

Transaction Breakdown

Companies & Roles

Discretionary Trading PnL

Holdings

Transaction History

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Insider Trading, Form 4 Filings & SEC Activity | Signal8